Chargement en cours...
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas
BACKGROUND: Fibrinogen-like protein 2 (FGL2) may promote glioblastoma multiforme (GBM) cancer development by inducing multiple immune-suppression mechanisms. METHODS: The biological significance of FGL2 expression was assessed using the The Cancer Genome Atlast (TCGA) glioma database and tumor lysat...
Enregistré dans:
| Publié dans: | J Natl Cancer Inst |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554195/ https://ncbi.nlm.nih.gov/pubmed/25971300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv137 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|